Lv34
250 积分 2024-09-03 加入
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
54分钟前
已完结
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
23小时前
已完结
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study
1天前
已完结
Genetic instabilities in human cancers
3个月前
已完结
Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection
7个月前
已完结
Opportunities and challenges for MRD assessment in the clinical management of multiple myeloma
8个月前
已完结
MRD in ALL: Optimization and Innovations
8个月前
已完结
皖公网安备34019202002308
